ホーム > 市場調査レポート > 医薬品

動物用医薬

市場調査レポート

商品コード

1511981

猫用ワクチンの市場規模、シェア、動向分析レポート：ワクチンタイプ別、疾患タイプ別、投与経路別、免疫期間別、コンポーネント別、地域別、およびセグメント予測、2024～2030年

Cat Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated), By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2024年06月27日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日

カスタマイズ可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

猫用ワクチン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の猫用ワクチン市場規模は2030年までに25億米ドルに達すると予測され、2024年から2030年までのCAGRは9.4%で拡大すると予測されています。

ペット飼育率の上昇、猫の新たな病気、可処分所得の増加は、猫用ワクチンの市場価値を高めると期待されています。さらに、製薬業界の投資も市場成長を後押しすると予想されています。

市場動向の高まりは、猫のワクチンの必要性、予防ヘルスケアの促進、猫の仲間の健康確保に対する飼い主の意識の高まりによるものです。ペットの飼い主は現在、ペットの食事のニーズや個人の価値観に合った製品を優先し、プレミアムで栄養価の高いペット用品を便利に入手できるオンラインペットブランドを利用しています。

猫用ワクチン市場レポートのハイライト

ワクチンタイプ別では、2023年に50.1%の最大売上シェアを獲得した改変/弱毒化生ワクチンが市場を独占しました。猫汎白血球減少症やヘルペスウイルスに対する改良/弱毒化生ワクチンの有効性が実証されたことで、ペットの飼い主と獣医師の信頼が高まった。
疾患タイプ別に見ると、猫呼吸器疾患（FRDs）セグメントは、FRDsの有病率の増加により、2023年に32.4％の最大シェアを占め、最終的に市場成長を牽引しています。
猫白血病セグメントは、予測期間中に9.8％の最速CAGRを示すと予測されています。
投与経路別では、注射剤が最大の市場シェアを占め、2023年には77.4%となります。ワクチン技術における継続的な研究開発が、注射剤市場を牽引しています。
免疫期間別では、1年ワクチンが2023年に50.1%と最大の市場シェアを占め、米国ネコ科開業医協会（AAFP）のような獣医学団体の熱心でエビデンスに基づいた実践が、安全で効果的なワクチン開発の指針となっています。
成分別では、混合ワクチンセグメントが2023年に64.0%と最大の市場シェアを占め、予測期間中にCAGR 9.5%と最速の成長が見込まれます。
2023年には、北米が38.1%の収益シェアで市場を独占したが、これは動物ワクチンを監督する厳格な規制と高品質のネコヘルスケア基準の維持に起因します。
主要企業には、Virbac;C.H. Boehringer Sohn AG &Co.KG.、Elanco、Zoetis、Merck &Co.、Bioveta, a.s.、Indian Immunologicals Ltd.などがあります。

地域別市場シェア分析、2023年および2030年
地域市場ダッシュボード
世界の地域市場スナップショット
市場規模と予測動向分析、2018年から2030年
北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- スウェーデン
- デンマーク
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第10章競合情勢

主要市場参入企業による最近の動向と影響分析
企業/競合の分類
ベンダー情勢
企業プロファイル
- Virbac
- CH Boehringer Sohn AG &Co. KG.
- Elanco
- Zoetis
- Merck &Co.
- Bioveta, as
- Indian Immunologicals Ltd

図表

List of Tables

Table 1 List of abbreviations
Table 2 North America cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 3 North America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 4 North America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 5 North America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 6 North America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 7 North America cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 8 U.S. cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 9 U.S. cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 10 U.S. cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 11 U.S. cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 12 U.S. cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 13 Canada cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 14 Canada cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 15 Canada cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 16 Canada cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 17 Canada cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 18 Europe cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 19 Europe cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 20 Europe cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 21 Europe cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 22 Europe cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 23 Europe cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 24 Germany cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 25 Germany cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 26 Germany cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 27 Germany cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 28 Germany cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 29 UK cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 30 UK cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 31 UK cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 32 UK cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 33 UK cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 34 France cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 35 France cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 36 France cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 37 France cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 38 France cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 39 Italy cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 40 Italy cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 41 Italy cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 42 Italy cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 43 Italy cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 44 Spain cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 45 Spain cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 46 Spain cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 47 Spain cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 48 Spain cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 49 Denmark cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 50 Denmark cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 51 Denmark cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 52 Denmark cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 53 Denmark cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 54 Sweden cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 55 Sweden cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 56 Sweden cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 57 Sweden cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 58 Sweden cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 59 Norway cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 60 Norway cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 61 Norway cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 62 Norway cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 63 Norway cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 64 Asia Pacific cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 65 Asia Pacific cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 68 Asia Pacific cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 69 Asia Pacific cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 70 China cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 71 China cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 72 China cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 73 China cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 74 China cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 75 Japan cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 76 Japan cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 77 Japan cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Japan cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 79 Japan cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 80 India cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 81 India cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 82 India cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 83 India cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 84 India cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 85 South Korea cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 86 South Korea cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 87 South Korea cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 88 South Korea cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 89 South Korea cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 90 Australia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 91 Australia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 92 Australia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 93 Australia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 94 Australia cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 95 Thailand cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 96 Thailand cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 97 Thailand cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 98 Thailand cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 99 Thailand cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 100 Latin America cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 101 Latin America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 102 Latin America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 103 Latin America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 104 Latin America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 105 Latin America cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 106 Brazil cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 107 Brazil cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 108 Brazil cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 109 Brazil cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 110 Brazil cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 111 Mexico cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 112 Mexico cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 113 Mexico cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 114 Mexico cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 115 Mexico cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 116 Argentina cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 117 Argentina cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 118 Argentina cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 119 Argentina cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 120 Argentina cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 121 MEA cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 122 MEA cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 123 MEA cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 124 MEA cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 125 MEA cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 126 MEA cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 127 South Africa cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 128 South Africa cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 129 South Africa cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 130 South Africa cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 131 South Africa cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 137 UAE cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 138 UAE cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 139 UAE cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 140 UAE cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 141 UAE cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 142 Kuwait cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 143 Kuwait cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 144 Kuwait cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 145 Kuwait cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 146 Kuwait cat vaccines market, by component, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cat vaccines market: market outlook
Fig. 9 Cat vaccines competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Cat vaccines market driver impact
Fig. 14 Cat vaccines market restraint impact
Fig. 15 Cat vaccines market: Vaccine type movement analysis
Fig. 16 Cat vaccines market: Vaccine type outlook and key takeaways
Fig. 17 Modified/Attenuated Live market estimates and forecast, 2018 - 2030
Fig. 18 Inactivated (Killed) estimates and forecast, 2018 - 2030
Fig. 19 Others estimates and forecast, 2018 - 2030
Fig. 20 Cat vaccines market: Disease type movement analysis
Fig. 21 Cat vaccines market: Disease type outlook and key takeaways
Fig. 22 Feline leukemia market estimates and forecasts, 2018 - 2030
Fig. 23 Feline panleukopenia market estimates and forecasts, 2018 - 2030
Fig. 24 Feline respiratory diseases market estimates and forecasts, 2018 - 2030
Fig. 25 Feline rabies diseases market estimates and forecasts, 2018 - 2030
Fig. 26 Other diseases market estimates and forecasts, 2018 - 2030
Fig. 27 Cat vaccines market: route of administration movement analysis
Fig. 28 Cat vaccines market: route of administration outlook and key takeaways
Fig. 29 Injectables market estimates and forecasts, 2018 - 2030
Fig. 30 Intranasal market estimates and forecasts, 2018 - 2030
Fig. 31 Oral market estimates and forecasts, 2018 - 2030
Fig. 32 Cat vaccines market: duration of immunity movement analysis
Fig. 33 Cat vaccines market: duration of immunity outlook and key takeaways
Fig. 34 1 Year market estimates and forecasts, 2018 - 2030
Fig. 35 3 Year market estimates and forecasts, 2018 - 2030
Fig. 36 Others market estimates and forecasts, 2018 - 2030
Fig. 37 Cat vaccines market: component movement analysis
Fig. 38 Cat vaccines market: component outlook and key takeaways
Fig. 39 Combined vaccines market estimates and forecasts, 2018 - 2030
Fig. 40 Mono vaccines market estimates and forecasts, 2018 - 2030
Fig. 41 Global cat vaccines market: Regional movement analysis
Fig. 42 Global cat vaccines market: Regional outlook and key takeaways
Fig. 43 Global cat vaccines market share and leading players
Fig. 44 North America market share and leading players
Fig. 45 Europe market share and leading players
Fig. 46 Asia Pacific market share and leading players
Fig. 47 Latin America market share and leading players
Fig. 48 Middle East & Africa market share and leading players
Fig. 49 North America: SWOT
Fig. 50 Europe SWOT
Fig. 51 Asia Pacific SWOT
Fig. 52 Latin America SWOT
Fig. 53 MEA SWOT
Fig. 54 North America, by country
Fig. 55 North America
Fig. 56 North America market estimates and forecasts, 2018 - 2030
Fig. 57 U.S.
Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
Fig. 59 Canada
Fig. 60 Canada market estimates and forecasts, 2018 - 2030
Fig. 61 Europe
Fig. 62 Europe market estimates and forecasts, 2018 - 2030
Fig. 63 UK
Fig. 64 UK market estimates and forecasts, 2018 - 2030
Fig. 65 Germany
Fig. 66 Germany market estimates and forecasts, 2018 - 2030
Fig. 67 France
Fig. 68 France market estimates and forecasts, 2018 - 2030
Fig. 69 Italy
Fig. 70 Italy market estimates and forecasts, 2018 - 2030
Fig. 71 Spain
Fig. 72 Spain market estimates and forecasts, 2018 - 2030
Fig. 73 Denmark
Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
Fig. 75 Sweden
Fig. 76 Sweden market estimates and forecasts, 2018 - 2030
Fig. 77 Norway
Fig. 78 Norway market estimates and forecasts, 2018 - 2030
Fig. 79 Asia Pacific
Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 81 China
Fig. 82 China market estimates and forecasts, 2018 - 2030
Fig. 83 Japan
Fig. 84 Japan market estimates and forecasts, 2018 - 2030
Fig. 85 India
Fig. 86 India market estimates and forecasts, 2018 - 2030
Fig. 87 Thailand
Fig. 88 Thailand market estimates and forecasts, 2018 - 2030
Fig. 89 South Korea
Fig. 90 South Korea market estimates and forecasts, 2018 - 2030
Fig. 91 Australia
Fig. 92 Australia market estimates and forecasts, 2018 - 2030
Fig. 93 Latin America
Fig. 94 Latin America market estimates and forecasts, 2018 - 2030
Fig. 95 Brazil
Fig. 96 Brazil market estimates and forecasts, 2018 - 2030
Fig. 97 Mexico
Fig. 98 Mexico market estimates and forecasts, 2018 - 2030
Fig. 99 Argentina
Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
Fig. 101 Middle East and Africa
Fig. 102 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 103 South Africa
Fig. 104 South Africa market estimates and forecasts, 2018 - 2030
Fig. 105 Saudi Arabia
Fig. 106 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 107 UAE
Fig. 108 UAE market estimates and forecasts, 2018 - 2030
Fig. 109 Kuwait
Fig. 110 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 111 Market share of key market players - Cat vaccines market

Product Code: GVR-4-68040-321-1

Cat Vaccine Market Growth & Trends:

The global cat vaccine market size is expected to reach USD 2.5 billion by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc.Rising pet ownership, emerging diseases in cats, and rising disposable income is expected to increase the market value for cat vaccines. Furthermore, pharmaceutical industry investments are also expected to boost market growth.

The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.

Cat Vaccine Market Report Highlights:

Based on vaccine type, the modified/attenuated live segment dominated the market with the largest revenue share of 50.1% in 2023. The demonstrated efficacy of modified/attenuated live vaccines against feline panleukopenia and herpesvirus, has boosted confidence in both pet owners and veterinarians.
Based on disease type, the feline respiratory diseases (FRDs) segment held the largest share of 32.4% in 2023 owing to the increasing prevalence of FRDs, eventually driving market growth.
The feline leukemia segment is anticipated to witness the fastest CAGR of 9.8% over the forecast period.
Based on route of administration, the injectables segment held the largest market share, with 77.4% in 2023. Continuous research and development in vaccine technology are propelling the injectables segment in the market.
Based on duration of immunity, the 1-year segment held the largest market share of 50.1% in 2023 and the diligent and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.
Based on component, the combined vaccine segment held the largest market share, with 64.0% in 2023, and is expected to grow at the fastest CAGR of 9.5% over the forecast period.
In 2023, North America dominated the market with a revenue share of 38.1% owing to the strict regulations overseeing animal vaccines and upholding high-quality feline healthcare standards.
Some of the major companies include Virbac; C.H. Boehringer Sohn AG & Co. KG.; Elanco; Zoetis; Merck & Co.; Bioveta, a.s.; Indian Immunologicals Ltd.; among others.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Vaccine type
- 1.2.2. Disease type
- 1.2.3. Route of administration
- 1.2.4. Duration of immunity
- 1.2.5. Component
- 1.2.6. Region
- 1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Vaccine type outlook
- 2.2.2. Disease type outlook
- 2.2.3. Route of administration outlook
- 2.2.4. Duration of immunity outlook
- 2.2.5. Component outlook
- 2.2.6. Regional outlook
2.3. Competitive Insights

Chapter 3. Cat Vaccines Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising pet ownership
  - 3.2.1.2. Emerging diseases in cats
  - 3.2.1.3. Rising disposable income
  - 3.2.1.4. Pharmaceutical industry investment
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent regulatory policies and regulations
  - 3.2.2.2. High cost of Vaccines
3.3. Cat Vaccines Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis

4.1. Vaccine Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Cat Vaccines Market by Vaccine Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Modified/attenuated (live)
  - 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Inactivated (killed)
  - 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Others
  - 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis

5.1. Disease Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Cat Vaccines Market by Disease Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Feline leukemia
  - 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Feline panleukopenia (Feline distemper)
  - 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Feline respiratory diseases
  - 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Feline rabies
  - 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Other diseases
  - 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis

6.1. Route of Administration Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Cat Vaccines Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Injectables
  - 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Intranasal
  - 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Oral
  - 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis

7.1. Duration of Immunity Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Cat Vaccines Market by Duration of Immunity Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.4.1. 1 Year
  - 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 7.4.2. 3 Years
  - 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Others
  - 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis

8.1. Component Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Cat Vaccines Market by Component Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 8.4.1. Combined vaccine
  - 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 8.4.2. Mono vaccine
  - 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.5. North America
- 9.5.1. U.S.
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/ reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2. Canada
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/ reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
- 9.6.1. UK
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/ reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2. Germany
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/ reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.3. France
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Regulatory framework/ reimbursement structure
  - 9.6.3.3. Competitive scenario
  - 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.4. Italy
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Regulatory framework/ reimbursement structure
  - 9.6.4.3. Competitive scenario
  - 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.5. Spain
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Regulatory framework/ reimbursement structure
  - 9.6.5.3. Competitive scenario
  - 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.6. Norway
  - 9.6.6.1. Key country dynamics
  - 9.6.6.2. Regulatory framework/ reimbursement structure
  - 9.6.6.3. Competitive scenario
  - 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.7. Sweden
  - 9.6.7.1. Key country dynamics
  - 9.6.7.2. Regulatory framework/ reimbursement structure
  - 9.6.7.3. Competitive scenario
  - 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.8. Denmark
  - 9.6.8.1. Key country dynamics
  - 9.6.8.2. Regulatory framework/ reimbursement structure
  - 9.6.8.3. Competitive scenario
  - 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
- 9.7.1. Japan
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/ reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2. China
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/ reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3. India
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/ reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4. Australia
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/ reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.5. South Korea
  - 9.7.5.1. Key country dynamics
  - 9.7.5.2. Regulatory framework/ reimbursement structure
  - 9.7.5.3. Competitive scenario
  - 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.6. Thailand
  - 9.7.6.1. Key country dynamics
  - 9.7.6.2. Regulatory framework/ reimbursement structure
  - 9.7.6.3. Competitive scenario
  - 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
- 9.8.1. Brazil
  - 9.8.1.1. Key country dynamics
  - 9.8.1.2. Regulatory framework/ reimbursement structure
  - 9.8.1.3. Competitive scenario
  - 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.2. Mexico
  - 9.8.2.1. Key country dynamics
  - 9.8.2.2. Regulatory framework/ reimbursement structure
  - 9.8.2.3. Competitive scenario
  - 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.3. Argentina
  - 9.8.3.1. Key country dynamics
  - 9.8.3.2. Regulatory framework/ reimbursement structure
  - 9.8.3.3. Competitive scenario
  - 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
- 9.9.1. South Africa
  - 9.9.1.1. Key country dynamics
  - 9.9.1.2. Regulatory framework/ reimbursement structure
  - 9.9.1.3. Competitive scenario
  - 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.2. Saudi Arabia
  - 9.9.2.1. Key country dynamics
  - 9.9.2.2. Regulatory framework/ reimbursement structure
  - 9.9.2.3. Competitive scenario
  - 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.3. UAE
  - 9.9.3.1. Key country dynamics
  - 9.9.3.2. Regulatory framework/ reimbursement structure
  - 9.9.3.3. Competitive scenario
  - 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.4. Kuwait
  - 9.9.4.1. Key country dynamics
  - 9.9.4.2. Regulatory framework/ reimbursement structure
  - 9.9.4.3. Competitive scenario
  - 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
10.4. Company Profiles
- 10.4.1. Virbac
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. C.H. Boehringer Sohn AG & Co. KG.
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. Elanco
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. Zoetis
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. Merck & Co.
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Bioveta, a.s.
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Indian Immunologicals Ltd
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product benchmarking
  - 10.4.7.4. Strategic initiatives

猫用ワクチンの市場規模、シェア、動向分析レポート：ワクチンタイプ別、疾患タイプ別、投与経路別、免疫期間別、コンポーネント別、地域別、およびセグメント予測、2024～2030年

Cat Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated), By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2030

全表示

猫用ワクチン市場の成長と動向：

猫用ワクチン市場レポートのハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章猫用ワクチン市場の変数、動向、範囲

第4章猫用ワクチン市場：ワクチンタイプ別推定・動向分析

第5章猫用ワクチン市場：疾患タイプ別推定・動向分析

第6章猫用ワクチン市場：投与経路別推定・動向分析

第7章猫用ワクチン市場：免疫期間別推定・動向分析

第8章猫用ワクチン市場：コンポーネント別推定・動向分析

第9章猫用ワクチン市場：地域推定・動向分析

第10章競合情勢

List of Tables

List of Figures

Cat Vaccine Market Growth & Trends:

Cat Vaccine Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cat Vaccines Market Variables, Trends & Scope

Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis

Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis

Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis

Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis

Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis

Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

猫用ワクチンの市場規模、シェア、動向分析レポート：ワクチンタイプ別、疾患タイプ別、投与経路別、免疫期間別、コンポーネント別、地域別、およびセグメント予測、2024～2030年

Cat Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated), By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2030

全表示

猫用ワクチン市場の成長と動向：

猫用ワクチン市場レポートのハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 猫用ワクチン市場の変数、動向、範囲

第4章 猫用ワクチン市場：ワクチンタイプ別推定・動向分析

第5章 猫用ワクチン市場： 疾患タイプ別推定・動向分析

第6章 猫用ワクチン市場：投与経路別推定・動向分析

第7章 猫用ワクチン市場： 免疫期間別推定・動向分析

第8章 猫用ワクチン市場：コンポーネント別推定・動向分析

第9章 猫用ワクチン市場：地域推定・動向分析

第10章 競合情勢

List of Tables

List of Figures

Cat Vaccine Market Growth & Trends:

Cat Vaccine Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cat Vaccines Market Variables, Trends & Scope

Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis

Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis

Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis

Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis

Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis

Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章猫用ワクチン市場の変数、動向、範囲

第4章猫用ワクチン市場：ワクチンタイプ別推定・動向分析

第5章猫用ワクチン市場：疾患タイプ別推定・動向分析

第6章猫用ワクチン市場：投与経路別推定・動向分析

第7章猫用ワクチン市場：免疫期間別推定・動向分析

第8章猫用ワクチン市場：コンポーネント別推定・動向分析

第9章猫用ワクチン市場：地域推定・動向分析

第10章競合情勢